Back to Trades
Cote Elissa S.
Chief Corp Development OfficerCIK 0002069951
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Cote Elissa S., Chief Corp Development Officer, has filed 1 SEC report (2026), all concentrated in Vistagen Therapeutics, Inc. (VTGN), totaling $40.2K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Apr 9 | VTGN Vistagen Therapeutics, Inc. | Cote Elissa S. | Chief Corp Development Officer | Award | $40.2K |
1 filing